REFERENCES
- Baranski, M. C., Silva, A. F., Kotaka, P. I., Gomes, N. R., Giovanni, M. & Telles, J. E. (1978). Tratamento da estrongiloidiase humana com novo anti-helmintico, o cambendazole, Estudo duplo cego. Revista do Instituto de Medicina Tropical de São Paulo, 20, 213–218.
- Campbell, W. C. (1981). An introduction to the avermectins. New Zealand Veterinary Journal, 29, 174–178.
- Dawkins, H. J. S. & Grove, D. I. (1981). Kinetics of primary and secondary infections with Strongyloides ratti in mice. International Journal for Parasitology, 11, 89–96.
- Dawkins, H. J. S. & Grove, D. I. (1982). Attempts to establish infections with Strongyloides stercoralis in mice and other laboratory animals. Journal of Helminthology 56, 23–26.
- Franz, K. H. (1963). Clinical trials with thiabendazole against human strongyloidiasis. American Journal of Tropical Medicine and Hygiene, 12, 211–214.
- Grove, D. I. (1982a). Treatment of strongyloidiasis with thiabendazole: an analysis of toxicity and effectiveness. Transactions of the Royal Society of Tropical Medicine and Hygiene, 76, 114–118.
- Grove, D. I. (1982b). Strongyloides ratti and S. stercoralis: the effects of thiabendazole, mebendazole and cambendazole in infected mice. American Journal of Tropical Medicine and Hygiene 31, 469–476.
- Kessler, W. & Stoye, M. (1971). Die Wirkung neuerer anthelminthika auf migriere larven von Ancylostoma caninum in der maus. Zeitschrift für Tropenmedizen und Parasitologie, 22, 49–56.
- Keystone, J. S. & Murdoch, J. K. (1979). Mebendazole. Annals of Internal Medicine, 91, 582–586.
- Scowden, E. B., Schaffner, W. & Stone, W. J. (1978). Overwhelming strongyloidiasis: an unappreciated opportunistic infection. Medicine (Baltimore), 57, 527–544.